Li, Wenyan
Wang, Wanxin
Lai, Wenjian
Li, Xiuwen
Zhu, Liwan
Shi, Jingman
Teopiz, Kayla M.
McIntyre, Roger S.
Guo, Lan
Lu, Ciyong
Funding for this research was provided by:
Natural Science Foundation of Guangdong Province (2019A1515011091)
National Natural Science Foundation of China (81761128030)
Article History
Received: 13 April 2022
Accepted: 15 November 2022
First Online: 30 November 2022
Declarations
:
: The study procedures were carried out in accordance with the Declaration of Helsinki. The study obtained ethical approval from the Sun Yat-sen University, School of Public Health Institutional Review Board (Ethics Number: L2017060). All participants and their legal guardians were informed in detail about the design and aims of the study and gave written informed consent to participate in the study, and written informed consent was obtained from each participant and one of the student’s legal guardians.
: Not applicable.
: Roger S. McIntyre has received research grant support from CIHR/GACD/National Natural Science Foundation of China (NSFC); speaker/consultation fees from Lundbeck, Janssen, Alkermes, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Abbvie, Atai Life Sciences. Roger S. McIntyre is the CEO of Braxia Scientific Corp. Kayla M. Teopiz has received personal fees from Braxia Scientific Corp.
: Rest all other authors have no competing interests to declare.